The management of myelofibrosis: a British Society for Haematology Guideline
McLornan, Donal P Psaila, Bethan Ewing, Joanne Innes, Andrew Arami, Siamak Brady, Jessica Butt, Nauman M Cargo, Catherine Cross, Nicholas C P Francis, Sebastian
McLornan, Donal P
Psaila, Bethan
Ewing, Joanne
Innes, Andrew
Arami, Siamak
Brady, Jessica
Butt, Nauman M
Cargo, Catherine
Cross, Nicholas C P
Francis, Sebastian
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-12-01
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015. These guidelines aim to provide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF), as well as postpolycythaemia myelofibrosis (post-PV MF) and postessential thrombocythaemia myelofibrosis (post-ET MF). A separate BSH guideline covers the diagnosis and prognostic evaluation of myelofibrosis and is published alongside this guideline.
Citation
McLornan DP, Psaila B, Ewing J, Innes A, Arami S, Brady J, Butt NM, Cargo C, Cross NCP, Francis S, Frewin R, Garg M, Godfrey AL, Green A, Khan A, Knapper S, Lambert J, McGregor A, McMullin MF, Nangalia J, Neelakantan P, Woodley C, Mead A, Somervaille TCP, Harrison CN; BSH Committee. The management of myelofibrosis: A British Society for Haematology Guideline. Br J Haematol. 2024 Jan;204(1):136-150. doi: 10.1111/bjh.19186. Epub 2023 Dec 1.
Type
Article